Skip to main content
. 2024 Mar 15;103(11):e37329. doi: 10.1097/MD.0000000000037329

Table 5.

Adverse reactions comparison.

Efficacy Observation group (n = 54) Control group (n = 51) χ2 P
Dry skin 1 (1.85) 3 (5.88)
Muscular pain 1 (1.85) 3 (5.88)
Dry lips 0 4 (7.84)
Facial desquamation 1 (1.85) 5 (9.80)
Overall incidence comparison 3 (5.56) 15 (29.41) 10.51 .001